Can I Get a Michigan Medical Marijuana Card for Cerebral Palsy?
Congenital movement disorder caused by perinatal brain injury, with spasticity, dystonia, and motor impairment.
Yes — cerebral palsy qualifies under the Michigan Medical Marihuana Program
Cerebral palsy is explicitly listed as a Category C qualifying condition on the Michigan MMMP Physician Certification Form. CP results from perinatal or early-childhood brain injury and produces a lifelong combination of motor impairment, spasticity, and (often) chronic pain. Many adult CP patients use medical cannabis to manage spasticity, pain, and sleep — symptoms that are tightly linked and often inadequately controlled by first-line antispastic medications.
Common symptoms
- Muscle spasticity (most common)
- Dystonia and abnormal posturing
- Motor impairment and gait abnormalities
- Chronic pain (musculoskeletal and neuropathic)
- Seizures (in some patients)
- Sleep disturbance
- Reduced ability to perform daily activities
How medical cannabis may help
THC and CBD reduce muscle spasticity through cannabinoid receptors in the central nervous system — an effect well-established in multiple sclerosis trials and increasingly recognized in CP and spinal cord injury patient populations. Cannabinoids also provide analgesia for the musculoskeletal pain that develops as CP patients age, and CBD is FDA-approved (as Epidiolex) for seizure disorders that affect some CP patients. The multi-symptom benefit is particularly valuable in CP — addressing spasticity, pain, sleep, and sometimes seizures with one therapy.
Evidence base
Direct CP-specific cannabis trials are limited, but spasticity evidence from multiple sclerosis (NASEM "substantial evidence") is generally considered applicable. Case series and patient surveys of CP populations report reduced spasticity, reduced pain, improved sleep, and reduced reliance on baclofen and benzodiazepines after adding cannabis. CBD-based therapy (Epidiolex) has direct evidence for seizures associated with several childhood-onset epilepsies that overlap with CP populations.
Michigan certification requirements
Documentation of your CP diagnosis (neurology or physical-medicine notes, MRI showing perinatal injury, or developmental records) is helpful. A list of current antispastic medications (baclofen, tizanidine, diazepam, botulinum toxin) and other therapies (PT, OT, orthotics) is useful. Pediatric patients require a designated caregiver per state rules.
Frequently Asked Questions
- Can children with cerebral palsy qualify in Michigan?
- Yes, with parental consent and a designated caregiver. Pediatric MMMP applications have additional documentation requirements. Dr. Vance will discuss the specific process for minor applicants during the consultation.
- Will cannabis help with my CP-related spasticity?
- For many CP patients, yes. Cannabis-derived spasticity reduction is well-established in multiple sclerosis and is generally considered applicable to CP. Cannabis is typically used alongside — not instead of — first-line antispastics like baclofen.
- How does the Michigan medical marijuana process work for a cerebral palsy patient who is a minor?
- Patients under 18 can qualify with a designated caregiver, typically a parent. The caregiver registers with the state alongside the patient. Michigan Category C conditions include cerebral palsy, and the MMMP recognizes pediatric access with appropriate documentation.
- Will the medical marijuana card affect my child's IEP or school services?
- Michigan MMMP data is confidential under MCL 333.26426(h) and is not reported to schools or IEP databases. If cannabis products need to be administered during the school day, that must be coordinated separately with school administration and typically requires school district approval.
- How does the phone consultation work for a patient with speech or communication differences?
- The visit is 10–15 minutes and caregivers can lead the conversation on behalf of patients with speech or communication differences. Dr. Vance is patient with alternative communication methods. Records from your neurologist or developmental pediatrician speed the evaluation.